122 related articles for article (PubMed ID: 36426572)
1. Loss of heterozygosity leading to incorrect HLA typing for platelet-transfusion refractory patient.
Horwath M; Tvrdik T; Saxe D; Deeb KK; Roback JD; Gebel HM; Bray RA; Sullivan HC
Transfusion; 2023 Jan; 63(1):263-268. PubMed ID: 36426572
[TBL] [Abstract][Full Text] [Related]
2. Pretransplant HLA typing revealed loss of heterozygosity in the major histocompatibility complex in a patient with acute myeloid leukemia.
Lobashevsky AL; Krueger-Sersen M; Britton RM; Littrell CA; Singh S; Cui CP; Kashi Z; Martin RK; Breman AM; Vance GH; Farag SS
Hum Immunol; 2019 Apr; 80(4):257-262. PubMed ID: 30790598
[TBL] [Abstract][Full Text] [Related]
3. Pretransplant HLA mistyping in diagnostic sample of a T-ALL patient due to loss of heterozygosity in the major histocompatibility complex.
Shi X; Li P; Hu R; Han W; Gao S
Transpl Immunol; 2021 Dec; 69():101463. PubMed ID: 34492296
[TBL] [Abstract][Full Text] [Related]
4. [Effect of Heterozygosity Loss in HLA Region before Transplantation on HLA Typing in Patients with Leukemia].
Zhao JW; Wang JY; Zhang Y; Li QH; Ru K; Wang XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):58-64. PubMed ID: 29397819
[TBL] [Abstract][Full Text] [Related]
5. Two cases of acute lymphoid leukemia patients with loss of heterozygosity in HLA region before transplantation.
Huang W; Xue S; Zhang Y; Liu F; Wang J
HLA; 2021 Sep; 98(3):207-212. PubMed ID: 34288574
[TBL] [Abstract][Full Text] [Related]
6. Leukemia specific loss of heterozygosity of MHC in a CLL patient: disease state impacts timing of confirmatory typing.
Coppage M; Iqbal A; Ahmad A; Becker MW
Hum Immunol; 2013 Jan; 74(1):41-4. PubMed ID: 23085343
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of loss of heterozygosity at HLA loci in a patient with leukemia].
Wang W; Wang F; Dong L; Chen N; He Y; Zhang W; He J; Zhu F
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Mar; 39(3):338-342. PubMed ID: 35315049
[TBL] [Abstract][Full Text] [Related]
8. HLA class I depletion by citric acid, and irradiation of apheresis platelets for transfusion of refractory patients.
Mirlashari MR; Vetlesen A; Nissen-Meyer LSH; Naper C; Tjønnfjord GE; Njerve IU; Ezligini F; Landmark BF; Meinke S; Sandgren P; Höglund P; Hetland G
Transfusion; 2021 Apr; 61(4):1222-1234. PubMed ID: 33580979
[TBL] [Abstract][Full Text] [Related]
9. Pretransplant HLA mistyping in diagnostic samples of acute myeloid leukemia patients due to acquired uniparental disomy.
Dubois V; Sloan-Béna F; Cesbron A; Hepkema BG; Gagne K; Gimelli S; Heim D; Tichelli A; Delaunay J; Drouet M; Jendly S; Villard J; Tiercy JM
Leukemia; 2012 Sep; 26(9):2079-85. PubMed ID: 22488219
[TBL] [Abstract][Full Text] [Related]
10. False homozygosity results in HLA genotyping due to loss of chromosome 6 in a patient with acute lymphoblastic leukemia.
Park H; Hyun J; Park SS; Park MH; Song EY
Korean J Lab Med; 2011 Oct; 31(4):302-6. PubMed ID: 22016688
[TBL] [Abstract][Full Text] [Related]
11. Recipient-derived HPA-1a antibodies: a cause of prolonged thrombocytopenia after unrelated donor stem cell transplantation.
Lucas G; Culliford S; Green F; Sidra G; Calvert A; Green A; Harrison P; Harvey J; Allen D; Smillie D; Masurekar A; Marks D; Russell N; Massey E
Transfusion; 2010 Feb; 50(2):334-9. PubMed ID: 19874563
[TBL] [Abstract][Full Text] [Related]
12. Somatic mutations in the HLA genes of patients with hematological malignancy.
Smith AG; Fan W; Regen L; Warnock S; Sprague M; Williams R; Nisperos B; Zhao LP; Loken MR; Hansen JA; Pereira S
Tissue Antigens; 2012 May; 79(5):359-66. PubMed ID: 22489945
[TBL] [Abstract][Full Text] [Related]
13. False-negative solid-phase platelet crossmatch results due to prozone phenomenon.
Horton RK; Zuccarelli MD; Wakefield LL; DiGuardo MA; Gandhi MJ; Juskewitch JE
Transfusion; 2020 Dec; 60(12):3055-3059. PubMed ID: 33047855
[TBL] [Abstract][Full Text] [Related]
14. Genetically engineered blood pharming: generation of HLA-universal platelets derived from CD34+ progenitor cells.
Figueiredo C; Blaszczyk R
J Stem Cells; 2014; 9(3):149-61. PubMed ID: 25157449
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of HLA-matched platelet transfusions for patients with hypoproliferative thrombocytopenia: a systematic review.
Pavenski K; Rebulla P; Duquesnoy R; Saw CL; Slichter SJ; Tanael S; Shehata N;
Transfusion; 2013 Oct; 53(10):2230-42. PubMed ID: 23550773
[TBL] [Abstract][Full Text] [Related]
16. Conflicting HLA assignment by three different typing methods due to the apparent loss of heterozygosity in the MHC region.
Linjama T; Impola U; Niittyvuopio R; Kuittinen O; Kaare A; Rimpiläinen J; Volin L; Peräsaari J; Jaatinen T; Lauronen J; Saarinen T; Juvonen E; Partanen J; Koskela S
HLA; 2016 May; 87(5):350-5. PubMed ID: 26969202
[TBL] [Abstract][Full Text] [Related]
17. Three patients highlighting potential pitfalls in platelet refractory testing.
Attieh M; Dent EA; Happney L; Roback JD; Alter DN; Barrette E; Then C; Sullivan HC
Transfusion; 2023 Apr; 63(4):888-892. PubMed ID: 36794568
[TBL] [Abstract][Full Text] [Related]
18. How do I … manage the platelet transfusion-refractory patient?
Juskewitch JE; Norgan AP; De Goey SR; Duellman PM; Wakefield LL; Gandhi MJ; Stubbs JR; Kreuter JD
Transfusion; 2017 Dec; 57(12):2828-2835. PubMed ID: 28960321
[TBL] [Abstract][Full Text] [Related]
19. HLA-universal platelet transfusions prevent platelet refractoriness in a mouse model.
Gras C; Schulze K; Goudeva L; Guzman CA; Blasczyk R; Figueiredo C
Hum Gene Ther; 2013 Dec; 24(12):1018-28. PubMed ID: 24090417
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of HLA virtual cross-matched platelet transfusions for platelet transfusion refractoriness in hematopoietic stem cell transplantation.
Seike K; Fujii N; Asano N; Ohkuma S; Hirata Y; Fujii K; Sando Y; Nakamura M; Naito K; Saeki K; Meguri Y; Asada N; Ennishi D; Nishimori H; Matsuoka KI; Tsubaki K; Otsuka F; Maeda Y
Transfusion; 2020 Mar; 60(3):473-478. PubMed ID: 31970799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
